214 related articles for article (PubMed ID: 20870446)
21. Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.
Banzo I; Jiménez-Bonilla J; Ortega-Nava F; Quirce R; Martínez-Rodríguez I; de Arcocha-Torres M; Rodríguez E; Vázquez JL; Sánchez PJ; Martínez-Amador N; Ibañez-Bravo S; Carril JM
Nucl Med Commun; 2014 Mar; 35(3):238-44. PubMed ID: 24240196
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
[TBL] [Abstract][Full Text] [Related]
23. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
24. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
[TBL] [Abstract][Full Text] [Related]
26. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
Brooks DJ
Mov Disord; 2009; 24 Suppl 2():S742-7. PubMed ID: 19877240
[TBL] [Abstract][Full Text] [Related]
27. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
[TBL] [Abstract][Full Text] [Related]
28. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
[TBL] [Abstract][Full Text] [Related]
29. [Cerebral glucose metabolism in Parkinson's disease with dementia].
Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710
[TBL] [Abstract][Full Text] [Related]
30. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.
Ibarretxe-Bilbao N; Ramírez-Ruiz B; Tolosa E; Martí MJ; Valldeoriola F; Bargalló N; Junqué C
J Neurol; 2008 Sep; 255(9):1324-31. PubMed ID: 18821043
[TBL] [Abstract][Full Text] [Related]
32. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
[TBL] [Abstract][Full Text] [Related]
33. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
[TBL] [Abstract][Full Text] [Related]
34. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
[TBL] [Abstract][Full Text] [Related]
35. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Okada J; Peppard R; Calne DB
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
[TBL] [Abstract][Full Text] [Related]
38. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
39. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
[TBL] [Abstract][Full Text] [Related]
40. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]